Renata L. Rao

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Tracking migraine outcomes over time by age and monoclonal antibody type: a retrospective, single-center, real-world study.

Tracking migraine outcomes over time by age and monoclonal antibody type: a retrospective, single-center, real-world study.

Journal: Frontiers in neurology

Published: May 28, 2026

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 07, 2026

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 05, 2026

Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study.

Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study.

Journal: Journal of neurology

Published: January 09, 2026

Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).

Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).

Journal: The journal of headache and pain

Published: July 28, 2025

Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study.

Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: April 08, 2025

The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectiveness.

The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectiveness.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 17, 2025

Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.

Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.

Journal: Headache

Published: December 20, 2024

Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study.

Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: October 24, 2024

Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).

Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).

Journal: Neurology and therapy

Published: October 21, 2023

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.

Journal: Toxins

Published: October 08, 2023

Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.

Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.

Journal: European journal of neurology

Published: August 22, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026